| PERIOD ENDING | 4-Sep-09 | 15-May-09 | 20-Feb-09 | 29-Nov-08 | | Total Revenue | 89,262 | 71,974 | 65,821 | 85,623 | | Cost of Revenue | 59,036 | 47,790 | 43,069 | 56,015 | | | Gross Profit | 30,226 | 24,184 | 22,752 | 29,608 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 18,062 | 20,265 | 19,181 | 25,363 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 6,119 |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 6,045 | 3,919 | 3,571 | 4,245 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (98) | 435 | 88 | 2,028 | | Earnings Before Interest And Taxes | 5,947 | 4,354 | 3,659 | 6,273 | | Interest Expense | 891 | 693 | 694 | 1,008 | | Income Before Tax | 5,056 | 3,661 | 2,965 | 5,265 | | Income Tax Expense | 2,617 | 1,954 | 2,408 | 3,109 | | Minority Interest | 436 | (18) | 188 | 36 | | | | Net Income From Continuing Ops | 2,875 | 1,689 | 745 | 1,917 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 2,875 | 1,689 | 745 | 1,917 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $2,875 | $1,689 | $745 | $1,917 |
|
0.41% Nasdaq 
0.02 (0.08%) 
Income Statement
